A
Alcista
Alcista · 25%PHOE
$10.01
Precio del escenario
$15.300
+0.306 (+2.00%)Al cierre
Loading chart…
- Máximo
- 15.300
- Apertura
- 15.300
- Precio medio ponderado por volumen
- 15.30
- Volumen
- 452.00
- Capitalización
- —
- Mínimo
- 15.300
- Importe
- 6.92K
- EV/EBITDA, TTM
- 0.00
Phoenix Asia Holdings Ltd is an investment holding company mainly engaged in the substructure works business. The Company is mainly engaged in site formation, ground investigation and foundation works business as subcontractor. The Company also provides other construction services such as structural steelworks, advisory services and supervision services in substructure projects.
Análisis de IA of Phoenix Asia Holdings Ltd (PHOE)
MantenerCurrently, Phoenix Asia Holdings Ltd (PHOE) is not a strong buy due to its low RSI of 21.517, indicating oversold conditions, and a significant 5-day change of -15.33%. While the stock has potential upside due to the recent acquisition news, the negative earnings projections and declining gross margin (down to 4.57% in Q4 2026) present risks. The stock's recent performance shows a 1-year change of -9.09%, suggesting a lack of momentum. Investors should monitor for signs of recovery before committing capital.
Métricas de valoración
El PER previsto actual de Phoenix Asia Holdings Ltd (PHOE) es 0.00, frente a su media de 5 años de 0.00.
Escenarios de precio de Alphio AI para PHOE
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Cronología de eventos
Noticias
8.505-05stocktwitsACEA Therapeutics to be Acquired by Phoenix Asia in $1 Billion Deal
8.505-05NewsfilterScilex Acquires ACEA Pharma for $1 Billion
8.505-05moomooSCILEX HOLDING CO - ACEA THERA TO ACQUIRE APPROXIMATELY 82% OF THE CONTINUING COMPANY AFTER CLOSURE
- 8.505-05moomoo
SCILEX HOLDING CO - PHOENIX TO CHANGE NAME TO ACEA PHARMA, INC. AND PLANS TO DEBUT ON NASDAQ
- 8.505-05moomoo
SCILEX HOLDING CO - ACEA THERA TO DIVEST ENTIRE STAKE IN ACEA PHARMA TO PHOENIX FOR $1 BILLION IN STOCK
Preguntas frecuentes sobre PHOE, respondidas por Alphio AI
Phoenix Asia Holdings Ltd is an investment holding company mainly engaged in the substructure works business. The Company is mainly engaged in site formation, ground investigation and foundation works business as subcontractor. The Company also provides other construction services such as structural steelworks, advisory services and supervision services in substructure projects. It operates in the Industrials sector.
Currently, Phoenix Asia Holdings Ltd (PHOE) is not a strong buy due to its low RSI of 21.517, indicating oversold conditions, and a significant 5-day change of -15.33%. While the stock has potential upside due to the recent acquisition news, the negative earnings projections and declining gross margin (down to 4.57% in Q4 2026) present risks. The stock's recent performance shows a 1-year change of -9.09%, suggesting a lack of momentum. Investors should monitor for signs of recovery before committing capital.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.